Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apolipoproteins A | 13 | 2016 | 27 | 2.110 |
Why?
|
| Internship and Residency | 3 | 2019 | 330 | 1.140 |
Why?
|
| Apolipoproteins B | 6 | 2016 | 49 | 0.980 |
Why?
|
| Physician-Patient Relations | 3 | 2019 | 188 | 0.980 |
Why?
|
| Death | 2 | 2018 | 53 | 0.920 |
Why?
|
| Triglycerides | 8 | 2016 | 249 | 0.780 |
Why?
|
| Interpersonal Relations | 2 | 2018 | 61 | 0.750 |
Why?
|
| Lipid Metabolism | 8 | 2013 | 113 | 0.720 |
Why?
|
| Lipoproteins, VLDL | 5 | 2016 | 27 | 0.710 |
Why?
|
| Milk | 1 | 2020 | 16 | 0.640 |
Why?
|
| Health | 1 | 2020 | 16 | 0.640 |
Why?
|
| Lipoproteins | 6 | 2008 | 99 | 0.600 |
Why?
|
| Child, Hospitalized | 1 | 2019 | 8 | 0.590 |
Why?
|
| Physician-Nurse Relations | 1 | 2018 | 4 | 0.580 |
Why?
|
| Nurse-Patient Relations | 1 | 2018 | 4 | 0.580 |
Why?
|
| Students, Medical | 1 | 2019 | 136 | 0.520 |
Why?
|
| Medical History Taking | 1 | 2016 | 41 | 0.500 |
Why?
|
| Protein Structure, Tertiary | 8 | 2010 | 118 | 0.490 |
Why?
|
| Protein Structure, Secondary | 4 | 2010 | 59 | 0.430 |
Why?
|
| Trust | 1 | 2014 | 45 | 0.410 |
Why?
|
| Medicine in Literature | 1 | 2013 | 2 | 0.410 |
Why?
|
| Mentors | 1 | 2013 | 35 | 0.400 |
Why?
|
| Intestinal Absorption | 1 | 2013 | 21 | 0.400 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2013 | 43 | 0.400 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 189 | 0.390 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 526 | 0.390 |
Why?
|
| Fatty Acids | 1 | 2013 | 108 | 0.380 |
Why?
|
| Funeral Rites | 1 | 2012 | 1 | 0.370 |
Why?
|
| Judaism | 1 | 2012 | 1 | 0.370 |
Why?
|
| Growth and Development | 1 | 2011 | 3 | 0.350 |
Why?
|
| Intestinal Mucosa | 2 | 2011 | 75 | 0.350 |
Why?
|
| Physicians | 1 | 2013 | 169 | 0.350 |
Why?
|
| Protein Isoforms | 2 | 2010 | 63 | 0.340 |
Why?
|
| Humans | 24 | 2019 | 34562 | 0.310 |
Why?
|
| Fatty Liver | 3 | 2016 | 70 | 0.280 |
Why?
|
| Animals | 13 | 2020 | 8578 | 0.280 |
Why?
|
| Spectrometry, Fluorescence | 5 | 2010 | 32 | 0.260 |
Why?
|
| Liver | 3 | 2016 | 513 | 0.260 |
Why?
|
| Diet | 2 | 2013 | 418 | 0.230 |
Why?
|
| Circular Dichroism | 4 | 2010 | 39 | 0.210 |
Why?
|
| Thermodynamics | 4 | 2010 | 57 | 0.210 |
Why?
|
| Transfection | 6 | 2012 | 216 | 0.200 |
Why?
|
| Schools, Medical | 1 | 2002 | 46 | 0.190 |
Why?
|
| Employment | 1 | 2002 | 52 | 0.180 |
Why?
|
| Cholesterol Esters | 1 | 2002 | 42 | 0.180 |
Why?
|
| Mutation | 3 | 2005 | 532 | 0.180 |
Why?
|
| Carrier Proteins | 4 | 2016 | 149 | 0.170 |
Why?
|
| Social Support | 1 | 2002 | 195 | 0.170 |
Why?
|
| Nitrogen Radioisotopes | 1 | 2019 | 2 | 0.160 |
Why?
|
| Ammonia | 1 | 2019 | 8 | 0.160 |
Why?
|
| Microcirculation | 1 | 2019 | 72 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2019 | 40 | 0.150 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2019 | 27 | 0.150 |
Why?
|
| Coronary Circulation | 1 | 2019 | 44 | 0.150 |
Why?
|
| Radiopharmaceuticals | 1 | 2019 | 103 | 0.150 |
Why?
|
| Spinal Puncture | 1 | 2019 | 22 | 0.150 |
Why?
|
| Injections, Spinal | 1 | 2019 | 124 | 0.140 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 46 | 0.140 |
Why?
|
| Coronary Vessels | 1 | 2019 | 180 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2019 | 124 | 0.140 |
Why?
|
| Ethics, Research | 1 | 2018 | 25 | 0.140 |
Why?
|
| Liposomes | 3 | 2007 | 34 | 0.140 |
Why?
|
| Informed Consent | 1 | 2018 | 45 | 0.140 |
Why?
|
| Water | 3 | 2008 | 70 | 0.130 |
Why?
|
| Female | 6 | 2019 | 21531 | 0.130 |
Why?
|
| Apolipoproteins | 3 | 2010 | 201 | 0.130 |
Why?
|
| Dietary Fats | 2 | 2011 | 115 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 20 | 0.120 |
Why?
|
| Abdominal Pain | 1 | 2016 | 44 | 0.120 |
Why?
|
| Diarrhea | 1 | 2016 | 59 | 0.120 |
Why?
|
| Lipids | 4 | 2005 | 267 | 0.120 |
Why?
|
| Spectrophotometry | 2 | 2008 | 22 | 0.120 |
Why?
|
| Protein Binding | 4 | 2007 | 255 | 0.120 |
Why?
|
| Recombinant Proteins | 4 | 2007 | 281 | 0.120 |
Why?
|
| Kinetics | 6 | 2007 | 259 | 0.120 |
Why?
|
| Infant | 1 | 2019 | 1123 | 0.120 |
Why?
|
| Male | 6 | 2019 | 20739 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2016 | 439 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2016 | 184 | 0.110 |
Why?
|
| Tetracycline | 2 | 2012 | 14 | 0.110 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 36 | 0.110 |
Why?
|
| Doxycycline | 2 | 2012 | 27 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 2 | 2004 | 24 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 628 | 0.100 |
Why?
|
| Protein Transport | 2 | 2012 | 82 | 0.100 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 8 | 0.100 |
Why?
|
| Particle Size | 2 | 2011 | 49 | 0.100 |
Why?
|
| COS Cells | 2 | 2003 | 33 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 842 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 319 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 389 | 0.100 |
Why?
|
| Dimyristoylphosphatidylcholine | 3 | 2007 | 6 | 0.090 |
Why?
|
| Stroke | 1 | 2018 | 700 | 0.090 |
Why?
|
| Rats | 3 | 2012 | 1946 | 0.090 |
Why?
|
| Culture Media | 1 | 2012 | 50 | 0.090 |
Why?
|
| Peptide YY | 1 | 2011 | 2 | 0.090 |
Why?
|
| Lymphatic Vessels | 1 | 2011 | 7 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 16 | 0.090 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2011 | 13 | 0.090 |
Why?
|
| Biological Transport | 1 | 2011 | 76 | 0.090 |
Why?
|
| Triolein | 2 | 2008 | 3 | 0.090 |
Why?
|
| Oleic Acid | 3 | 2010 | 7 | 0.090 |
Why?
|
| Mice | 3 | 2013 | 2720 | 0.090 |
Why?
|
| Chickens | 2 | 2008 | 40 | 0.090 |
Why?
|
| Catheterization | 1 | 2011 | 62 | 0.090 |
Why?
|
| Aged | 4 | 2019 | 11022 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 216 | 0.080 |
Why?
|
| Eating | 1 | 2011 | 81 | 0.080 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2010 | 2 | 0.080 |
Why?
|
| Middle Aged | 4 | 2019 | 12726 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2010 | 41 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2010 | 207 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 781 | 0.080 |
Why?
|
| Body Weight | 1 | 2011 | 343 | 0.080 |
Why?
|
| Chylomicrons | 2 | 2005 | 6 | 0.070 |
Why?
|
| Adsorption | 1 | 2008 | 6 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2008 | 11 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2011 | 366 | 0.070 |
Why?
|
| Adult | 3 | 2019 | 10030 | 0.070 |
Why?
|
| Gene Expression | 2 | 2013 | 363 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2005 | 35 | 0.060 |
Why?
|
| Golgi Apparatus | 2 | 2004 | 10 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2006 | 101 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2005 | 70 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2005 | 111 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 432 | 0.060 |
Why?
|
| Intestines | 1 | 2005 | 66 | 0.060 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2005 | 39 | 0.060 |
Why?
|
| Apolipoprotein A-I | 1 | 2005 | 69 | 0.060 |
Why?
|
| Protein Sorting Signals | 1 | 2004 | 6 | 0.050 |
Why?
|
| Cholesterol | 2 | 2005 | 273 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2003 | 13 | 0.050 |
Why?
|
| Tritium | 1 | 2003 | 19 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2016 | 486 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2003 | 29 | 0.050 |
Why?
|
| Air | 1 | 2003 | 7 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 88 | 0.050 |
Why?
|
| Protein Folding | 1 | 2003 | 31 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 74 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 99 | 0.050 |
Why?
|
| Software | 1 | 2003 | 130 | 0.050 |
Why?
|
| Postprandial Period | 1 | 2002 | 11 | 0.050 |
Why?
|
| Teaching | 1 | 2002 | 65 | 0.050 |
Why?
|
| Pressure | 1 | 2002 | 70 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 124 | 0.040 |
Why?
|
| Time Factors | 2 | 2005 | 2353 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 1607 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 1209 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2003 | 430 | 0.040 |
Why?
|
| Genotype | 1 | 2002 | 744 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 14 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 1523 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2019 | 31 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 87 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 108 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2019 | 258 | 0.040 |
Why?
|
| Disulfides | 2 | 2010 | 43 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 926 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 939 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 4137 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1034 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2016 | 56 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 291 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 337 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 204 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 45 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 277 | 0.030 |
Why?
|
| Atherosclerosis | 2 | 2013 | 837 | 0.030 |
Why?
|
| Cell Line | 2 | 2005 | 476 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 6 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2010 | 6 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 21 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 29 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 52 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2010 | 111 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1128 | 0.020 |
Why?
|
| Cysteine | 1 | 2010 | 145 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2008 | 116 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 889 | 0.020 |
Why?
|
| Calcinosis | 1 | 2008 | 150 | 0.020 |
Why?
|
| Radiography | 1 | 2008 | 397 | 0.020 |
Why?
|
| Adiposity | 1 | 2008 | 204 | 0.020 |
Why?
|
| Copper Sulfate | 1 | 2006 | 1 | 0.020 |
Why?
|
| Amidines | 1 | 2006 | 4 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 34 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 66 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 528 | 0.020 |
Why?
|
| Guanidine | 1 | 2006 | 4 | 0.010 |
Why?
|
| Octoxynol | 1 | 2006 | 9 | 0.010 |
Why?
|
| Histidine | 1 | 2006 | 7 | 0.010 |
Why?
|
| Buffers | 1 | 2006 | 12 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 2006 | 20 | 0.010 |
Why?
|
| Spodoptera | 1 | 2006 | 5 | 0.010 |
Why?
|
| Detergents | 1 | 2006 | 18 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2005 | 31 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2006 | 56 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 43 | 0.010 |
Why?
|
| Light | 1 | 2006 | 42 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 30 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 38 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 46 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 77 | 0.010 |
Why?
|
| Phenylalanine | 1 | 2005 | 5 | 0.010 |
Why?
|
| Oils | 1 | 2005 | 3 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 150 | 0.010 |
Why?
|
| Amino Acids | 1 | 2006 | 54 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 282 | 0.010 |
Why?
|
| Antioxidants | 1 | 2006 | 126 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 114 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2006 | 92 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 143 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2005 | 14 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2005 | 89 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 281 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 233 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 92 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 204 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 100 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 328 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 265 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 1910 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 545 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 755 | 0.010 |
Why?
|